The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Sameer Goel & PACs

pdf

Kimia Biosciences Ltd.

12 Aug 2024

43.00

-2.56%

SAST

Kimia Biosciences Ltd - 530313 - Disclosures under Reg. 10(6) of SEBI (SAST) Regulations, 2011

BSE India

The Exchange has received the disclosure under Regulation 10(6) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Sameer Goel

pdf

Kimia Biosciences Ltd.

12 Aug 2024

43.00

-2.56%

Company Update

Kimia Biosciences Ltd - 530313 - Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance …

BSE India

Dear Sir, Pursuant to Regulation 30 of SEBI (Listing Obligation and Disclosure Requirement) Regulations, 2015, this is to inform you that Mr. Lakshay Prakash, Company Secretary & Compliance Officer has resigned from his services and accordingly, shall ceased to be the Company Secretary & Compliance Officer and KMP of the Company with effect from close of business hours of Monday, August 12, 2024.

pdf

Kimia Biosciences Ltd.

12 Aug 2024

43.00

-2.56%

SAST

Kimia Biosciences Ltd - 530313 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

BSE India

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Deepa Goel

pdf

Kimia Biosciences Ltd.

09 Aug 2024

43.00

-2.56%

Company Update

Kimia Biosciences Ltd - 530313 - Intimation Under Regulation 30 Of SEBI (Listing Obligation And Disclosure …

BSE India

Dear Sir/ Madam, The Company is pleased to inform that the Company has filed its Quality Product for API, Benfotiamine in European Union in Bulgaria.

pdf

Kimia Biosciences Ltd.

06 Aug 2024

43.00

-2.56%

Board Meeting

Kimia Biosciences Ltd - 530313 - Board Meeting Intimation for Intimation Of Board Meeting For Adoption …

BSE India

Kimia Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2024 ,inter alia, to consider and approve This is to inform that a meeting of Board of Directors is scheduled to be held on Wednesday, August 14, 2024 at 03.00 pm (IST) at the corporate office of the Company 974, 9th Floor, Aggarwal Millennium Tower-II, Netaji Subhash Place, Pitampura, New Delhi-110034 to transact the following businesses, amongst others: 1) To consider and approve the un-audited financial results on standalone basis of the Company for quarter and three months ended June 30, 2024 in accordance with Regulation 33 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015; 2) Any other matter as may be considered and transacted with permission of Board of Directors.

pdf

Kimia Biosciences Ltd.

03 Aug 2024, 04:28PM

43.00

-2.56%

SAST

Kimia Biosciences Ltd - 530313 - Disclosures under Reg. 10(5) in respect of acquisition under Reg. …

BSE India

The Exchange has received the disclosure under Regulation 10(5) in respect of acquisition under Regulation 10(1)(a) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Sameer Goel

pdf

Kimia Biosciences Ltd.

02 Aug 2024, 04:06PM

43.00

-2.56%

Corp. Note

Kimia Biosciences Ltd - 530313 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / …

BSE India

Dear Sir/ Madam, This is with reference to the earlier intimation dated 30.07.2024 regarding the request received for issuance of duplicate share certificate in lieu of the loss original share certificates.

pdf

Kimia Biosciences Ltd.

30 Jul 2024

43.00

-2.56%

Corp. Note

Kimia Biosciences Ltd - 530313 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / …

BSE India

Dear Sir/ Madam, Pursuant to Regulation 39(3) of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015. The Company has received the intimation from our Registrar & Transfer Agent, Beetal Financial Computers Services Private Limited regarding they issuance of duplicate share certificates.

pdf

No results found

Is Kimia Biosciences Ltd. worth buying?

14 Votes:

Buy 71.43%

Sell 7.14%

Hold 21.43%